S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.92 (+0.21%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.92 (+0.21%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.92 (+0.21%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.92 (+0.21%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
OTCMKTS:NGENF

NervGen Pharma Short Interest Ratio and Short Volume

$2.29
+0.05 (+2.23%)
(As of 12/3/2021 03:59 PM ET)
Add
Compare
Today's Range
$2.25
$2.33
50-Day Range
$1.68
$2.49
52-Week Range
$1.05
$2.67
Volume
16,300 shs
Average Volume
42,303 shs
Market Capitalization
$141.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

NervGen Pharma (OTCMKTS:NGENF) Short Interest Data

Current Short Volume
14,900 shares
Previous Short Volume
6,500 shares
Change Vs. Previous Month
+129.23%
Dollar Volume Sold Short
$37.10 thousand
Short Interest Ratio / Days to Cover
0.0
Last Record Date
November, 15 2021
Outstanding Shares
61,770,000 shares
Percentage of Shares Shorted
0.02%
Today's Trading Volume
16,300 shares
Average Trading Volume
42,303 shares
Today's Volume Vs. Average
-61.47%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling NervGen Pharma ?

Sign up to receive the latest short interest report for NervGen Pharma and its competitors with MarketBeat's FREE newsletter.

NervGen Pharma (OTCMKTS:NGENF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202114,900 shares $37.10 thousand +129.2%N/A0 $2.49
10/29/20216,500 shares $15.18 thousand +6,400.0%N/A0 $2.34
10/15/2021100 shares $189.00 -99.4%N/A0 $1.89
9/30/202115,800 shares $29.70 thousand No ChangeN/A0.3 $1.88
8/31/20211,800 shares $2.97 thousand -73.5%N/A0 $1.65
8/13/20216,800 shares $11.41 thousand +65.9%N/A0.2 $1.68
7/30/20214,100 shares $5.78 thousand +64.0%N/A0.1 $1.41
7/15/20212,500 shares $3.51 thousand No ChangeN/A0 $1.40
6/30/20212,500 shares $3.15 thousand -82.0%N/A0 $1.26
6/15/202113,900 shares $17.24 thousand +195.7%N/A0.1 $1.24
5/28/20214,800 shares $5.23 thousand -11.1%N/A0.3 $1.09
5/14/20215,400 shares $6.35 thousand +42.1%N/A0.2 $1.18
4/30/20213,800 shares $5.40 thousand +65.2%N/A0.1 $1.42
4/15/20212,300 shares $3.13 thousand -79.1%N/A0.1 $1.36
3/31/202111,000 shares $14.70 thousand +746.2%N/A0.3 $1.34
3/15/20211,300 shares $2.01 thousand -50.0%N/A0 $1.55
2/26/20212,600 shares $4.58 thousand -71.7%N/A0.1 $1.76
2/12/20219,200 shares $17.76 thousand +70.4%N/A0.3 $1.93
1/29/20215,400 shares $10.55 thousand +2,600.0%N/A0.1 $1.95
12/31/20202,100 shares $3.56 thousand No ChangeN/A0.1 $1.70
11/30/2020900 shares $1.22 thousand -52.6%N/A0 $1.36
11/15/20201,900 shares $2.72 thousand -5.0%N/A0.1 $1.43
10/30/20202,000 shares $2.48 thousand -59.2%N/A0.1 $1.24
10/15/20204,900 shares $5.28 thousand +1,125.0%N/A0.1 $1.08
9/30/20201,700 shares $1.71 thousand -95.3%N/A0.1 $1.00













NervGen Pharma (OTCMKTS:NGENF) Short Interest Frequently Asked Questions

What is NervGen Pharma's current short interest?

Short interest is the volume of NervGen Pharma shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 14,900 shares of NGENF short. Learn More on NervGen Pharma's current short interest.

Is NervGen Pharma's short interest increasing or decreasing?

NervGen Pharma saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 14,900 shares, an increase of 129.2% from the previous total of 6,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does NervGen Pharma's short interest compare to its competitors?

0.00% of NervGen Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NervGen Pharma: Oramed Pharmaceuticals Inc. (0.00%), Fulcrum Therapeutics, Inc. (10.04%), ORIC Pharmaceuticals, Inc. (9.46%), VBI Vaccines Inc. (8.57%), OrganiGram Holdings Inc. (0.00%), Applied Molecular Transport Inc. (10.13%), SIGA Technologies, Inc. (3.11%), Enochian Biosciences, Inc. (3.73%), ESSA Pharma Inc. (5.58%), and Chimerix, Inc. (3.22%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short NervGen Pharma stock?

Short selling NGENF is an investing strategy that aims to generate trading profit from NervGen Pharma as its price is falling. NervGen Pharma's stock is trading up $0.05 today. To short NervGen Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that NervGen Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NervGen Pharma?

A short squeeze for NervGen Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NGENF, which in turn drives the price of the stock up even further.

How often is NervGen Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGENF, twice per month. The most recent reporting period available is November, 15 2021.



This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.